• Wed, July 24, 2019
  • Mon, July 22, 2019
  • Tue, July 23, 2019

Paul Choi Initiated (BBIO) at Strong Buy and Held Target at $42 on, Jul 22nd, 2019

Paul Choi of Goldman Sachs, Initiated "BridgeBio Pharma, Inc." (BBIO) at Strong Buy and Held Target at $42 on, Jul 22nd, 2019.

Paul, nor any peers, have made any analyst calls on BBIO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍